Efficacy of combined treatment with pirfenidone and PD-L1 inhibitor in mice bearing ectopic bladder cancer xenograft

CONCLUSION: Combined treatment with pirfenidone and PD-L1 inhibitor significantly inhibits the progression of bladder cancer in mice possibly by regulating tumor immune microenvironment and inhibiting epithelial-mesenchymal transition of the tumor cells.PMID:38501405 | PMC:PMC10954534 | DOI:10.12122/j.issn.1673-4254.2024.02.02
Source: Journal of Southern Medical University - Category: Universities & Medical Training Authors: Source Type: research